Quantifying the Costs of Care Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated in the Veterans Health Administration

JAMA Netw Open. 2021 Mar 1;4(3):e213816. doi: 10.1001/jamanetworkopen.2021.3816.
No abstract available

Publication types

  • Comment

MeSH terms

  • BCG Vaccine
  • Humans
  • Neoplasm Recurrence, Local
  • Urinary Bladder Neoplasms* / therapy
  • Veterans Health
  • Veterans*

Substances

  • BCG Vaccine